Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism

Maria Cristina Vedovati; Andrés J. Muñoz Martín; Michela Giustozzi; Paula Jiménez‐Fonseca; Cecilia Becattini; María Purificación Martínez del Prado; Francesco Dentali; Menno V. Huisman; Alexander T. Cohen; Rupert Bauersachs; Alberto Carmona‐Bayonas; Giancarlo Agnelli

doi:10.1016/j.ejim.2025.04.016

Related publications

Article2023

Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism

Maria Cristina Vedovati, Michela Giustozzi, Andrés J. Muñoz Martín, Laurent Bertoletti, Alexander T. Cohen, Frederikus A. Klok, Jean M. Connors, Rupert Bauersachs, Benjamin Brenner, Mauro Campanini, Cecilia Becattini, Giancarlo Agnelli

Article2025

Optimising the Caravaggio score: developing a more universally applicable and comprehensive venous thromboembolism risk stratification tool. Author’s reply

Maria Cristina Vedovati, Giancarlo Agnelli

Article2020

Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study

Walter Ageno, Maria Cristina Vedovati, Ander Cohen, Menno V. Huisman, Rupert Bauersachs, Gualberto Gussoni, Cecilia Becattini, Giancarlo Agnelli

Article2018

Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

Giancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs, Benjamin Brenner, Mauro Campanini, Alexander T. Cohen, Jean M. Connors, Andrea Fontanella, Gualberto Gussoni, Menno V. Huisman, Catherine Lambert, Guy Meyer, Andrés J. Muñoz Martín, Joaquim Abreu de Sousa, Adam Torbicki, Melina Verso, Giorgio Vescovo

Letter2012

A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

Melina Verso, Giancarlo Agnelli, Sandro Barni, Giampietro Gasparini, Roberto Labianca

Internal and Emergency Medicine